Differences in nasal fluid levels of myeloperoxidase (MPO) and fucose after lavage with saline and histamine solutions, respectively, may indicate a neutrophil inflammation in the nasal mucosa in patients with COPD, and moreover, a glandular Source: Eur Respir J 2002; 20: Suppl. 38, 93s Year: 2002
Quantitative proteomics on nasal lavage fluid from asthma phenotypes Source: Annual Congress 2012 - New mechanisms in non-neoplastic and neoplastic lung diseases Year: 2012
Comparison of cellular composition of induced sputum, bronchial washing and bronchoalveolar lavage fluid in some interstitial lung diseases Source: Eur Respir J 2002; 20: Suppl. 38, 313s Year: 2002
Measurement of inflammatory factors in nasal lavage liquid in asthmatic children Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control Year: 2010
Detection of extracellular proteasome in the human alveolar space Source: Annual Congress 2006 - Molecular airway biology Year: 2006
Evaluation of upper airway involvement and interleukin-8 levels in nasal lavage fluid of stable COPD patients Source: Annual Congress 2011 - COPD mechanisms Year: 2011
Comparison of the diagnostic value of immunological test, applied to two types of biological fluids - venous blood and bronchoalveolar lavage in children with tuberculosis Source: International Congress 2018 – Diagnosis of tuberculosis Year: 2018
Genetic variation in nasal lavage fluid proteins and association with allergic rhinitis Source: Eur Respir J 2007; 30: Suppl. 51, 536s Year: 2007
The effect of fluticasone on the airway inflammatory response to organic dust Source: Eur Respir J 2004; 24 : 587-593 Year: 2004
Serum and nasal lavage fluid Clara cell protein in children with allergic rhinitis Source: Annual Congress 2011 - Biomarkers of allergic inflammation Year: 2011
Normal nasal mucociliary clearance in CF children: evidence against a CFTR-related defect Source: Eur Respir J 2004; 24: 95-100 Year: 2004
SPLUNC1, a putative mediator of host defence, is predominantly localised in the mucous gland cells of the upper airways, nose and oral cavity Source: Eur Respir J 2004; 24: Suppl. 48, 554s Year: 2004
Correlation between nasal inflammation and COVID-19 related pneumonia evaluated by nasal cytology. Source: Virtual Congress 2021 – COVID - 19: lessons learned Year: 2021
Cellular and cytokinic patterns in nasal lavage fluid of children with seasonal rhino-conjunctivitis Source: Eur Respir J 2002; 20: Suppl. 38, 423s Year: 2002
Changes in pro-inflammatory cytokines in association with exposure to moisture-damaged building microbes Source: Eur Respir J 2001; 18: 951-958 Year: 2001
Elevated concentrations of CXCL8 in the nasal mucosal lining fluid of COPD patients as an accessible surrogate measure of bronchial levels Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016
Upper airways symptoms, nasal lavage cells and eicosanoids in COPD Source: Annual Congress 2009 - Quality of life and symptoms in COPD Year: 2009
Limited role for bronchoalveolar lavage to exclude COVID-19 after negative upper respiratory tract swabs: a multicentre study Source: Eur Respir J, 56 (4) 2001733; 10.1183/13993003.01733-2020 Year: 2020
Lipid-laden macrophage index and inflammation in bronchoalveolar lavage fluids in children Source: Eur Respir J 2001; 18: 790-795 Year: 2001
Comparison between bronchoalveolar lavage fluid and tracheobronchial secretions cultures in pneumonia etiological diagnosis Source: Eur Respir J 2004; 24: Suppl. 48, 548s Year: 2004